Research News and Research

RSS

ACS podcast on medical adhesive

Scientists questing after a long-sought new medical adhesive describe copying the natural glue secreted by a tiny sea creature called the sandcastle worm in the latest episode in the American Chemical Society's (ACS) award-winning podcast series, "Global Challenges/Chemistry Solutions."

28 Oct 2009

QB3 collaborates with Mission Bay Capital Fund to provide startup capital for UC scientists

The California Institute of Quantitative Biosciences (QB3) is collaborating with a newly launched $7.5 million fund to provide startup capital for University of California bioscience entrepreneurs and a long-term endowment for QB3.

28 Oct 2009

Lovelace Respiratory Research Institute and Brigham and Women's Hospital collaborate on respiratory diseases research

Lovelace Respiratory Research Institute (LRRI) recently announced the formation of a research agreement between the Division of Pulmonary and Critical Care Medicine of the Department of Medicine at Brigham and Women's Hospital (BWH), teaching hospital of Harvard Medical School in Boston.

28 Oct 2009

United States Patent and Trademark Office allows a patent application within ‘Esau’ patent family

Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), announced today that the United States Patent and Trademark Office (USPTO) has allowed a patent application within the ‘Esau’ patent family (US Application Serial No. 10/909,125).

28 Oct 2009

Pure Protein develops soluble Class II human leukocyte antigens

Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.

28 Oct 2009

Accenture Innovation Center for Health launched to tackle challenges facing the global health industry

Accenture (NYSE: ACN) today launched the Accenture Innovation Center for Health in response to the growing global demand for insights into and strategies to confront the top health issues and challenges affecting citizens worldwide. The center serves as the focal point for Accenture’s thought capital and proven assets for tackling the most pressing challenges facing the global health industry.

28 Oct 2009

Scientists discover that bacteria have the capability to clean wastewater

Sam Houston State University has applied for six federal patents, three of which have already been awarded, to protect the technology and engineering associated with a "revolutionary" packaged wastewater treatment system invented by its scientists, and it has formed a company to further develop, market and sell the systems.

28 Oct 2009

Third-quarter fiscal 2009 results announced by Neovasc

Neovasc Inc., today announced financial results for the three and nine months ended September 30, 2009.

28 Oct 2009

Design of a consultation room can improve the quality of a visit to the physician's office

The design of a consultation room can improve the quality of a visit to the physician's office. A collaborative research study developed by Nurture by Steelcase and Mayo Clinic, was conducted to understand the extent to which a consultation room designed to support present-day clinical encounters could affect the consultation between patients and clinicians.

28 Oct 2009

Dyax reports financial results for third quarter 2009; attracts a net loss of $0.17 per share

Dyax Corp. today announced financial results for the third quarter ended September 30, 2009. Dyax will host a webcast and conference call at 10 a.m. (ET) this morning to review the financial results and corporate progress for the quarter.

28 Oct 2009

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

Results from the largest prospective controlled ulcerative colitis (UC) trial conducted to date, called the QD dosing investigation for efficacy IN UC maintenance (QDIEM), found that once-daily dosing of Asacol(R) (mesalamine) delayed-release 400 mg tablets at 1.6-2.4 g/day was comparable to twice-daily dosing for the maintenance of remission in patients with UC.

28 Oct 2009

SciClone Pharmaceuticals reduces its U.S.-based workforce by 17% in research and development

SciClone Pharmaceuticals, Inc. today announced a corporate restructuring that will reduce its U.S.-based workforce by approximately 17%, primarily in research and development. This restructuring follows the discontinuation of SciClone's RP101 phase 2 clinical trial announced on October 2, 2009.

28 Oct 2009

MolecularMD moves core operations to expanded facility

MolecularMD Corp announced today that it has moved their core operations to a expanded dedicated facility with capacity and functionality to support the expansion of its cancer molecular diagnostics business.

28 Oct 2009

Majority of parents want schools to limit students' access to high-calorie foods

The vast majority of parents want schools to limit students' access to high-calorie chips, sodas and candy and to offer them opportunities for physical activity throughout the day, a new survey by the Alliance for a Healthier Generation shows.

28 Oct 2009

Ascent Healthcare Solutions to reprocess the SoundStar 3D Diagnostic Ultrasound Catheter

Ascent Healthcare Solutions, a leader in delivering healthcare resource sustainability, today announced that it has received the industry’s first and only 510(k) clearance from the U.S. Food and Drug Administration (FDA) to reprocess the Biosense Webster SoundStar™ 3D Diagnostic Ultrasound Catheter. With this new clearance, Ascent continues to lead the charge in bringing sustainability to healthcare.

28 Oct 2009

Arrayit sells NanoPrint Microarrayer system to CENAT

Arrayit Corporation today announced the sale of a system to the Center of Excellence for Nucleic Acid-Based Technologies (CENAT) in Poznan, Poland. The Arrayit NanoPrint Microarrayer will be used by CENAT for scientific and medical collaborations throughout the prosperous democracy.

28 Oct 2009

Auxilium Pharmaceuticals reports increased net revenues of $42.1 million in third quarter 2009

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2009. For the third quarter of 2009, Auxilium reported net revenues of $42.1 million compared to net revenues of $32.6 million in the third quarter of 2008.

28 Oct 2009

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.

28 Oct 2009

NSF awards $3 million grant for establishing a Partnership in Research and Education in Materials

Professor Morris is principal investigator on a new, five-year $3 million National Science Foundation (NSF) grant that establishes a Partnership in Research and Education in Materials (PREM) at CCNY in collaboration with the University of Chicago's Materials Research Science and Engineering Center. The "overarching goal of the partnership is to develop methodology for description of material dynamics" as an emerging branch of materials science.

28 Oct 2009

Veterans with TBI vision loss have poor quality of life compared to civilian patients

Pan-American Association of Ophthalmology (PAAO) Joint Meeting, includes a Veterans Administration study that indicates that Iraq and Afghanistan veterans with vision loss from traumatic brain injury have significantly poorer quality of life than comparable civilian patients, and a Harvard doctor's insights on how to best evaluate and care for low-vision patients who experience vivid visual hallucinations due to Charles Bonnet syndrome.

28 Oct 2009

Research News and Research

ACS podcast on medical adhesive

QB3 collaborates with Mission Bay Capital Fund to provide startup capital for UC scientists

Lovelace Respiratory Research Institute and Brigham and Women's Hospital collaborate on respiratory diseases research

United States Patent and Trademark Office allows a patent application within ‘Esau’ patent family

Pure Protein develops soluble Class II human leukocyte antigens

Accenture Innovation Center for Health launched to tackle challenges facing the global health industry

Scientists discover that bacteria have the capability to clean wastewater

Third-quarter fiscal 2009 results announced by Neovasc

Design of a consultation room can improve the quality of a visit to the physician's office

Dyax reports financial results for third quarter 2009; attracts a net loss of $0.17 per share

Controlled trial in UC meets primary endpoint of non- inferiority for reducing ulcerative colitis

SciClone Pharmaceuticals reduces its U.S.-based workforce by 17% in research and development

MolecularMD moves core operations to expanded facility

Majority of parents want schools to limit students' access to high-calorie foods

Ascent Healthcare Solutions to reprocess the SoundStar 3D Diagnostic Ultrasound Catheter

Arrayit sells NanoPrint Microarrayer system to CENAT

Auxilium Pharmaceuticals reports increased net revenues of $42.1 million in third quarter 2009

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

NSF awards $3 million grant for establishing a Partnership in Research and Education in Materials

Veterans with TBI vision loss have poor quality of life compared to civilian patients

A guide to advancing biotherapeutic research eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms